India has been one of the biggest pharmaceutical partners of Philippines and accounts for almost 12.6 percent of the total pharmaceutical imports into the country. Global Data predicts that the pharmaceutical market in Philippines will grow to reach $3.7 billion, in 2025 after the introduction of the UHC Act in Feb’ 2019. This will enable a further increase in the already high Indian pharmaceutical imports. Indian generics entered the Philippines market after the introduction of the Generics Act in 1988, and since then, they witnessed an upward uptake trend in this import driven market. The primary reason for this dominance of Indian imports is their cost-effectiveness. These Indian pharmacies get access to low-cost raw materials and a skilled workforce which enables them to supply products at most competitive prices while maintaining the quality. As a result, it is much more viable for the pharmacies to outsource their products from India, rather than relying on the pharmaceutical manufacturers in Philippines. Being one of the Indian companies in the pharma market of Philippines, Neumedica Helathcare get a definite competitive advantage above others. We get the opportunity to collaborate with one of the top pharmacies in the country, and our client base is increasing day by day. If you also have a pharmaceutical business in Philippines and want to partner with us, you can feel free to contact us